Standard retrograde pancreatosplenectomy versus radical antegrade modular pancreatosplenectomy for body and tail pancreatic adenocarcinoma

American Surgeon

Volumn 79, Issue 11, 2013, Pages 1154-1158

  Latorre, Marco ^a   Ziparo, Vincenzo ^a   Nigri, Giuseppe ^a   Balducci, Genoveffa ^a   Cavallini, Marco ^a   Ramacciato, Giovanni ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COHORT ANALYSIS; COLON RESECTION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GASTRECTOMY; HOSPITALIZATION; HUMAN; LYMPH NODE DISSECTION; MALE; MORBIDITY; NEPHRECTOMY; OPERATION DURATION; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS FISTULA; PANCREAS SURGERY; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; RADICAL ANTEGRADE MODULAR PANCREATOSPLENECTOMY; RETROSPECTIVE STUDY; STANDARD RETROGRADE PANCREATOSPLENECTOMY; SURGICAL APPROACH; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL RATE; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION;

ADENOCARCINOMA; FEMALE; HUMANS; LENGTH OF STAY; LYMPH NODE EXCISION; MALE; MIDDLE AGED; PANCREATECTOMY; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES; SPLENECTOMY; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84886702280     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Winter JM, Cameron JL, Campbell KA, et al. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 2006;10: 1199-211.
2. Lillemoe KD, Kaushal S, Cameron JL, et al. Distal pancreatectomy: indications and outcomes in 235 patients. Ann Surg 1999;229: 693-8.
3. Fernandez-del Castillo C, Rattner DW, Warshaw AL. Standards for pancreatic resection in the 1990s. Arch Surg 1995;130: 295-9.
4. Conlon KC, Brennan MF. Management of adenocarcinoma of the body and tail of the pancreas. In: Cameron JL, ed. Atlas of Clinical Oncology: Pancreatic Cancer. Ontario, Canada: DC Decker, Inc; 2001: 255-63.
5. La Torre M, Nigri G, Ferrari L, et al. Hospital volume, margin status, and long-term survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg 2012;78: 225-9.
6. Mitchem JB, Hamilton N, Gao F, et al. Long-term results of resection of adenocarcinoma of the body and tail of the pancreas using radical antegrade modular pancreatosplenectomy procedure. J Am Coll Surg 2012;214: 46-52.
7. La Torre M, Nigri G, Cavallini M, et al. The Glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma. Ann Surg Oncol 2012;19: 2917-23.
8. Strasberg SM, Drebin JA, Linehan D. Radical antegrade modular pancreatosplenectomy. Surgery 2003;133: 521-7.
9. Bassi C, Dervenis C, Butturini G, et al. International Study Group on Pancreatic Fistula Definition. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005;138: 8-13.
10. Strasberg SM, Linehan DC, Hawkins WG, et al. Radical antegrade modular pancreatosplenectomy procedure for adenocarcinoma of the body and tail of the pancreas: ability to obtain negative tangential margins. J Am Coll Surg 2007;204: 244-9.
11. Slidell MB, Chang DC, Cameron JL, et al. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis. Ann Surg Oncol 2008;15: 165-74.
12. La Torre M, Cavallini M, Ramacciato G, et al. Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis. J Surg Oncol 2011;104: 629-33.
13. Kang CM, Kim DH, Lee WJ. Ten years of experience with resection of left-sided pancreatic ductal adenocarcinoma: evolution and initial experience to a laparoscopic approach. Surg Endosc 2010;24: 1533-41.
14. Howard TJ, Krug JE, Yu J, et al. A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer. J Gastrointest Surg 2006;10: 1338-45.
15. Redmond KJ, Wolfgang CL, Sugar EA, et al. Adjuvant chemoradiation therapy for adenocarcinoma of the distal pancreas. Ann Surg Oncol 2010;17: 3112-9.